Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Connect with this vendor - Learn about this product

Paxman Scalp Cooling System

The Paxman Scalp Cooling System (PSCS) has been developed by the Paxman family to reduce hair loss in breast cancer patients undergoing chemotherapy. The PSCS a compact, mobile refrigeration unit that has been tested to IEC 60601 safety standards for medical devices.  The unit contains a coolant which is cooled and circulated through a specially designed flexible silicone Paxman Cooling Cap which is positioned on the patient's head. It has an easy-to-read touchscreen visual display with clear status graphics and there is a range of cap sizes to ensure optimised fit for the patient.  They system is available for either single or dual patient use.

Scalp cooling is clinically proven to be an effective way of combatting Chemotherapy Induced Alopecia across a wide range of cheomotheraypy regimes.  It can result in a high level of retention or completely preserve the hair. For patients, this means the opportunity to regain some control, maintain privacy and encourage a positive attitude towards treatment.  It works by reducing the temperature of the scalp a few degrees, before, during and after the administration of chemotherapy.

Biological studies, as a result of the collaboration between Paxman and the University of Huddersfield have provided a greater understanding of the mechanisms by which cooling protects against drug-induced toxicity and are in direct support of the established clinical efficacy of cooling.  Investing in scientific testing and development has allowed us to attain the highest levels of technical precision and clinical efficacy of our cold cap.